The Global Phototherapy Treatment Industry is estimated to be worth US$ 1,948.90 million in 2023 and is projected to be valued at US$ 3,230.90 million in 2033. Between 2023 and 2033, the industry is expected to register a CAGR of 5.20%.
The increasing prevalence of skin ailments such as psoriasis and eczema across the globe and the advancement of phototherapy technology are expected to influence the global market for phototherapy treatment over the forecast period. The aging population is more prone to skin disorders, and this demographic trend has boosted the demand for phototherapy services. With a larger aging population, there is a higher need for phototherapy treatment options.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-na-4297
The increasing incidence of skin disorders such as psoriasis, eczema, vitiligo, and atopic dermatitis has been a significant driver. Phototherapy is a well-established and effective treatment for many of these conditions. Ongoing advancements in phototherapy technology have led to the development of more efficient and patient-friendly devices.
As awareness of the effectiveness of phototherapy as a treatment option for various skin disorders increases, more patients and healthcare providers are opting for this non-invasive treatment. The growing acceptance of phototherapy is contributing to market growth.
Increased healthcare spending by both governments and individuals has allowed for greater access to phototherapy treatments. Health insurance coverage for phototherapy services has also made the treatment more accessible to patients.
The phototherapy treatment market is expanding in emerging economies as healthcare infrastructure improves and more people seek treatment for skin disorders. The market is growing not only in developed countries but also in regions with a rising middle-class population.
Global Phototherapy Treatment Industry Key Takeaways
- In 2022, the phototherapy treatment market was valued at US$ 1,838.10 billion.
- Based on disease type, the acne segment is expected to account for a share of 60.4% in 2023.
- Based on phototherapy, the blue light therapy segment is expected to account for a share of 42.20% in 2023.
- Global phototherapy treatment demand in China is predicted to account for a CAGR of 6.70% through 2033.
- Phototherapy treatment in the United States is expected to account for a CAGR of 2.30% between 2023 and 2033.
- Germany is projected to expand by a value CAGR of 3.10% between 2023 and 2033.
- By 2033, the phototherapy treatment market in India is anticipated to record a CAGR of 7.80% during the forecast period.
“The increasing number of people suffering from acne and psoriasis and growing technological advances in healthcare are anticipated to drive the market growth during the forecast period,” says an FMI analyst.
Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-na-4297
Global Phototherapy Treatment Industry Competitive Landscape
The global phototherapy treatment market depicts a fragmented competitive landscape due to numerous players in the market. The key players in the market have adopted innovative strategies like mergers, partnerships, and acquisitions to enhance their market presence and strengthen their market hold.
- GE Healthcare provides a wide range of healthcare solutions, including phototherapy equipment used in neonatal care for conditions like jaundice.
- Lumenis is a global medical technology company known for its aesthetic and medical equipment, including phototherapy devices for dermatological treatments.
- TheraLight is a company specializing in light therapy technology for various medical and dermatological applications, including skin conditions and wound care.
Valuable Insights Available
Future Market Insights offers an unbiased global phototherapy treatment Industry analysis, providing historical data from 2018 to 2022 and forecast statistics between 2023 and 2033.
To understand opportunities in the phototherapy treatment market, the market is segmented based on Disease Type (Psoriasis, Acne) by Phototherapy Type (Blue light therapy, red light phototherapy, Intense Pulsed Light (IPL) Phototherapy, Narrowband UVB Phototherapy, Psoralens+Ultravioletlight A (PUVA) Phototherapy) by End-user(Hospitals, Dermatology Clinics/Skin Care Centres, Wellness Centres, Home Care Settings) Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, the Middle East, and Africa).
Global Phototherapy Treatment Industry Key Companies Profiled
- Lifespan
- UC Irvine Health
- Buffalo Medical Group
- Blackrock Clinic Limited
- The Private Phototherapy Clinic Ltd
- National Skin Centre Massachusetts General Hospital
- Signify Holding
- GE Healthcare
- Natus Medical Incorporated
Get Ahead with Comprehensive Information – Purchase Now!
https://www.futuremarketinsights.com/checkout/4297
Global Phototherapy Treatment Industry – Key Segments
By Disease Type:
- Psoriasis
- Guttate Psoriasis
- Inverse Psoriasis
- Pustular Psoriasis
- Erythrodermic Psoriasis
- Plaque Psoriasis
- Acne
- Acne Vulgaris
- Acne Conglobata
- Acne Fulminans
- Gram-Negative Folliculitis
- Acne Rosacea
- Pyoderma Faciale
By Phototherapy Type:
- Blue Light Phototherapy
- Red Light Phototherapy
- Intense Pulsed Light (IPL) Phototherapy
- Narrowband UVB Phototherapy
- Psoralens+Ultravioletlight A (PUVA) Phototherapy
By End User:
- Hospitals
- Dermatology Clinics/Skin Care Centres
- Wellness Centres
- Home Care Settings
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
About the Healthcare Division at Future Market Insights
The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube